The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data
Abstract
Accurate diagnostic classification of cancers can greatly help physicians to choose surveillance and treatment strategies for patients. Following the explosive growth of huge amounts of biological data, the shift from traditional biostatistical methods to computer-aided means has made machine-learning methods as an integral part of today's cancer prognosis prediction. In this work, we proposed a classification model by leveraging the power of extreme gradient boosting (XGBoost) and using increasingly complex multi-omics data with the aim to separate early stage and late stage cancers. We applied XGBoost model to four kinds of cancer data downloaded from TCGA and compared its performance with other popular machine-learning methods. The experimental results showed that our method obtained statistically significantly better or comparable predictive performance. The results of this study also revealed that DNA methylation outperforms other molecular data (mRNA expression and miRNA expression) in terms of accuracy and stability for discriminating between early stage and late stage groups. Furthermore, integration of multi-omics data by autoencoder can enhance the classification accuracy of cancer stage. Finally, we conducted bioinformatics analyses to assess the medical utility of the significant genes ranked by their importance using XGBoost algorithm. Extensively comparative experiments demonstrated that the XGBoost method has a remarkable performance in predicting the stage of cancer patients with multi-omics data. Moreover, identification of novel candidate genes associated with cancer stages would contribute to further elucidate disease pathogenesis and develop novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · arXiv · doi:10.48550/arxiv.1603.02754 · Cited by 7,104
Approximate Statistical Tests for Comparing Supervised Classification Learning Algorithms
Dietterich, T. G. (1998) · Neural Computation · doi:10.1162/089976698300017197 · Cited by 3,840
Machine Learning Applications in Cancer Prognosis and Prediction
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.005 · Cited by 3,338
The sequence of sequencers: The history of sequencing DNA
Heather, J. M., & Chain, B. (2016) · Genomics · doi:10.1016/j.ygeno.2015.11.003 · Cited by 1,397
Deep learning-based multi-omics integration robustly predicts survival in liver cancer
Chaudhary, K., Poirion, O. B., Lu, L., & Garmire, L. X. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0853 · Cited by 1,091
Cancer metabolism: current perspectives and future directions
Muñoz-Pinedo, C., El Mjiyad, N., & Ricci, J.-E. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.123 · Cited by 385
Cited by
Using machine learning approaches for multi-omics data analysis: A review
Reel, P. S., Reel, S., Pearson, E., Trucco, E., & Jefferson, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107739 · Cited by 903
Artificial intelligence assists precision medicine in cancer treatment
Liao, J., Li, X., Gan, Y., Han, S., Rong, P., Wang, W., Li, W., & Zhou, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.998222 · Cited by 256
Integrating multi-omics data with EHR for precision medicine using advanced artificial intelligence
Tong, L., Shi, W., Isgut, M., Zhong, Y., Lais, P., Gloster, L., Sun, J., Swain, A., Giuste, F., & Wang, M. D. (2024) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2023.3324264 · Cited by 130
Bernardini, M., Doinychko, A., Romeo, L., Frontoni, E., & Amini, M.-R. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107188 · Cited by 42
Wang, H., Lin, K., Zhang, Q., Shi, J., Song, X., Wu, J., Zhao, C., & He, K. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae159 · Cited by 30
“Ma et al . combined mRNA features with DNA methylation data to form an integrated feature set and used the XGBoost model to classify cancer patients (Ma et al .”
Method
Metadata
- Authors
- Ma, B., Meng, F., Yan, G., Yan, H., Chai, B., & Song, F.
- Venue
- Computers in Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 121
- Pages
- 103761
- ISSN
- 0010-4825 (ISSN-L)
- OpenAlex
- W3017142950
- Cited by
- 220
- References
- 10
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data. https://app.cochat.ai/papers/10.1016/j.compbiomed.2020.103761
- The paper
- Ma, B., Meng, F., Yan, G., Yan, H., Chai, B., & Song, F. (2020). Diagnostic classification of cancers using extreme gradient boosting algorithm and multi-omics data. Computers in Biology and Medicine. https://doi.org/10.1016/j.compbiomed.2020.103761
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.